Clinical Pharmacology of 5-Fluorouracil
- 1 April 1989
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 16 (4) , 215-237
- https://doi.org/10.2165/00003088-198916040-00002
Abstract
5-Fluorouracil, first introduced as a rationally synthesised anticancer agent 30 years ago, continues to be widely used in the management of several common malignancies including cancer of the colon,...Keywords
This publication has 99 references indexed in Scilit:
- The effect of 5-fluorouracil on DNA chain elongation in intact bone marrow cellsBiochemical and Biophysical Research Communications, 1985
- Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugsCancer Treatment Reviews, 1982
- Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetasePharmacology & Therapeutics, 1981
- The incorporation of 5-fluoro-2′-deoxyuridine into DNA of mammalian tumor cellsBiochemical and Biophysical Research Communications, 1981
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979
- Inhibition of transfer RNA function by replacement of uridine and uridine-derived nucleosides with 5-fluorouridineBiochemistry, 1978
- Antineoplastic DrugsDrugs, 1978
- Fluorouracil Therapy in Patients With Carcinoma of the Large BowelClinical Pharmacokinetics, 1978
- Combination chemotherapy: The interaction of methotrexate and 5-fluorouracilPublished by Elsevier ,1973
- Nucleic acid related compounds. III. Facile synthesis of 5-fluorouracil bases and nucleosides by direct fluorinationJournal of the American Chemical Society, 1971